about
Ketogenic diet in neuromuscular and neurodegenerative diseasesVitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid lifeUntangling tau imagingOlfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and DiseaseIntracellular Calcium Dysregulation: Implications for Alzheimer's DiseaseSomatic mutations in disorders with disrupted brain connectivityNatural Phytochemicals in the Treatment and Prevention of Dementia: An OverviewAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsKilling Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's DiseaseAmyloid-β and Astrocytes Interplay in Amyloid-β Related DisordersThe Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's DiseaseEpigenetic Alterations in Alzheimer's DiseaseInvolvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseTau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic ParaplegiaDissecting Alzheimer disease in Down syndrome using mouse modelsFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesNeurodegeneration and microtubule dynamics: death by a thousand cutsThe Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's DiseaseMisframed ubiquitin and impaired protein quality control: an early event in Alzheimer's diseaseAlzheimer's Disease associated with Psychiatric ComorbiditiesA genetic cause of Alzheimer disease: mechanistic insights from Down syndromeRegulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genesMetabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and TreatmentMitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's DiseaseRole of P2X7 and P2Y2 receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation "in vivo" by P2X7 receptorChronochemistry in neurodegenerationProtein prenylation and synaptic plasticity: implications for Alzheimer's diseaseBehavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's DiseasesEpidemiology of Alzheimer diseaseMitochondrial oxidative stress in aging and healthspanEntorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy modelsGulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War Illness3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic MiceWhy looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis.Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's DiseaseNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
P2860
Q21284703-4B32B259-742F-4CE1-9060-5B01F3CB35BCQ24186855-5BF0860B-454C-4871-A3DA-22204560E9CCQ26739091-013F15A7-36DB-482E-83C4-DD35089D9C80Q26741605-AFB0EAC0-8526-4955-ADAA-29D369B537B5Q26747203-F6A24998-C5F9-40EB-BEBE-1D0773C0A987Q26747309-27275B80-693E-4D22-AF34-18A974A0BEB9Q26750581-C010AB9F-8A8A-4A03-A954-912529959F1AQ26751302-E82C4574-10F6-4F2A-BCC7-E339D16805F0Q26765824-F9DA65B1-68E5-4A52-83CB-04719A58D194Q26766934-DBBD1D27-E648-4FF0-9102-A662A1D5E971Q26768487-EC7DF81D-4377-4263-837A-42FFA90FD4A1Q26770475-3488A425-714C-4C61-89F0-C64C5D81A4C8Q26771266-BFA19C3B-34C0-4860-BA17-2CB6F585F834Q26773154-A1078400-FC6A-4A42-9A0A-E9BF94F189A8Q26774045-BC0B5C00-B202-47F8-9312-05C3C1581356Q26777254-738F7451-DAE8-43F3-96BF-CAB9C22CECC9Q26779933-2F85C22D-E5F3-48C3-9EF4-20B21BE56A54Q26781649-DF18FA03-71C0-4D7E-A88C-0E2A0ACC35E7Q26781815-50853620-1065-45A2-A100-CB78026E0066Q26782999-6F43750C-A443-4987-B188-E4617C74279BQ26796602-C952CD02-CD2B-47E4-B8E4-3485B4588E26Q26798983-B8E4DF12-D82C-425E-9AE5-64E74E72A652Q26799208-C41BC80A-68A7-409D-AA9C-9CBF4C87B654Q26799893-AE438F16-1E31-4805-A072-BA5C005B5A99Q26801929-9CE7AE9B-803A-410F-92B5-3E3CA1886866Q26824248-38FD748B-ABB7-49E7-B0A3-DF6F6AE038D3Q26830057-CEB7FF6D-44C0-45FB-B423-FD180A2FDA6CQ26858942-6CA1A254-E9E6-40A3-B1BD-7C88EBC153CCQ26858963-C01CA108-C320-4492-A5A6-36EB719EC6B7Q26859141-494862CD-8B4A-449C-98D6-08DEE390D845Q26865371-6EC0766C-60B3-4CBA-BD7A-CE677477A7FDQ27025099-880E51AB-C10E-4BBA-98B8-35E2D96568A2Q27307826-76067615-50C1-4962-94AE-04FC4FE3FA05Q27308146-BC59ADB1-EF2F-4AE7-8748-5504BBD06CC1Q27312033-F4DD04C2-21A7-43E3-B866-026D3C66E0B6Q27334236-12779375-0DD2-434C-9E91-9919F52D6691Q27692592-3ACB7090-C898-42B0-8941-7ABF5AF7B3C4Q28068353-162B6372-B3EC-4B8C-AE1A-3EBE2FFE32A4Q28070156-FCF2A85E-0B13-430E-AD41-363E4DE0E3CDQ28082768-91B99D89-CAAF-4466-B33D-D20483CB9253
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Neuropathological alterations in Alzheimer disease
@ast
Neuropathological alterations in Alzheimer disease
@en
Neuropathological alterations in Alzheimer disease
@nl
type
label
Neuropathological alterations in Alzheimer disease
@ast
Neuropathological alterations in Alzheimer disease
@en
Neuropathological alterations in Alzheimer disease
@nl
prefLabel
Neuropathological alterations in Alzheimer disease
@ast
Neuropathological alterations in Alzheimer disease
@en
Neuropathological alterations in Alzheimer disease
@nl
P2093
P2860
P3181
P1476
Neuropathological alterations in Alzheimer disease
@en
P2093
A. Serrano-Pozo
B. T. Hyman
E. Masliah
M. P. Frosch
P2860
P304
P3181
P356
10.1101/CSHPERSPECT.A006189
P407
P577
2011-09-01T00:00:00Z